Case File
efta-efta01446881DOJ Data Set 10CorrespondenceEFTA Document EFTA01446881
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01446881
Pages
0
Persons
0
Integrity
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
Healthcare
Original
Modified
Current
Total
Equity
Bristol Myers [GMT)
5
2.50
5
2:00
$
2.00
Pfizer [PPE)
5
2.50
5
2.00
5
2.00
Merck (MRK)
$
2.50
5
2.00
$
2.00
Valeant (VRX)
$
1.50
5
1.00
5
1.00
Actayis (ACT)
S
1.50
5
1.03
$
1.00
Gilead [GILD)
$
1.50
5
1.10 5
0.40 $
1.50
Myl a n [MVO
$
1.00
$
1.00
5
1.00
Endo Health (ENDP)
$
1.00
5
1.00
5
1.00
HCA Holdings (MCA)
5
0.50
$
1.00
$
1.00
Rite Aid 'RAD)
$
0.50
5
0.50
5
0.50
Foundation Medical [FMI)
5
0.70 5
0.70
Ariad [ARIA)
5
0.10 $
0.10
Sangamo Biosciences (56M0
5
1.00 $
1.00
Biogen IBIlB)
5
0.50
$
0.60 $
1.10
Agerion [AEGR)
5
0.50
$
0.50
WS Carernark [DA)
5
1.00
5
1.00
Healthcare Sub Total
$
15.00
$
14.60 5
2.80 $
17.40
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e)
DB-SDNY-0 101305
CONFIDENTIAL
SDNY_GM_00247489
EFTA01446881
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.